Siemionow Maria, Unal Sakir
Department of Plastic Surgery, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Ann Plast Surg. 2005 Nov;55(5):545-53. doi: 10.1097/01.sap.0000182657.35457.8b.
Recent advances in the field of reconstructive surgery and immunology resulted in increased interest in composite tissue allograft (CTA) transplantation. Up to date, more than 50 CTA transplants have been reported in humans. A significant number of experimental studies on CTA transplants under different protocols of tolerance-inducting strategies have been reported in small-animal models. There is however, a limited number of CTA transplants performed in nonhuman primates. To reach the ultimate clinical success in CTA transplantation, more experimental studies on tolerance induction in nonhuman primates are needed to apply these immunomodulatory protocols to CTA transplants in humans. In this review, strategies for tolerance induction in the nonhuman primate model in solid organ and CTA transplants are presented in 3 major categories: chimerism induction, T-cell depletion, and costimulatory receptor blockade.
重建外科和免疫学领域的最新进展引发了人们对复合组织同种异体移植(CTA)的更大兴趣。迄今为止,已有超过50例CTA移植在人体中得到报道。在小动物模型中,已经报道了大量关于不同诱导耐受策略方案下CTA移植的实验研究。然而,在非人灵长类动物中进行的CTA移植数量有限。为了在CTA移植中取得最终的临床成功,需要在非人灵长类动物中进行更多关于诱导耐受的实验研究,以便将这些免疫调节方案应用于人体的CTA移植。在这篇综述中,实体器官和CTA移植中非人灵长类动物模型诱导耐受的策略分为三大类:嵌合体诱导、T细胞清除和共刺激受体阻断。